You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

VITAMIN A PALMITATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vitamin A Palmitate patents expire, and when can generic versions of Vitamin A Palmitate launch?

Vitamin A Palmitate is a drug marketed by Arcum, Banner Pharmacaps, and Bel Mar. and is included in five NDAs.

The generic ingredient in VITAMIN A PALMITATE is vitamin a palmitate. There are fifty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vitamin a palmitate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for VITAMIN A PALMITATE?
  • What are the global sales for VITAMIN A PALMITATE?
  • What is Average Wholesale Price for VITAMIN A PALMITATE?
Summary for VITAMIN A PALMITATE
Drug patent expirations by year for VITAMIN A PALMITATE
Recent Clinical Trials for VITAMIN A PALMITATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Beijing Ditan HospitalNA
Beijing Electric Power HospitalNA
Jiangsu Province Nanjing Brain HospitalPHASE4

See all VITAMIN A PALMITATE clinical trials

US Patents and Regulatory Information for VITAMIN A PALMITATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arcum VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083311-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Banner Pharmacaps VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083981-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Arcum VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083321-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Banner Pharmacaps VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083948-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Vitamin A Palmitate

Last updated: February 20, 2026

Vitamin A palmitate remains a significant compound within the vitamin A supplement market, driven by applications in pharmaceuticals, nutraceuticals, and fortified foods. The market's growth, influenced by regulatory environments, manufacturing capacity, and health trends, is forecasted to expand with a compound annual growth rate (CAGR) of approximately 5-7% over the next five years.


What Are Key Factors Shaping the Vitamin A Palmitate Market?

Supply Chain and Production Capacity

  • The primary producers are located in China, India, and the United States, accounting for over 70% of global output.
  • Global capacity was estimated at approximately 2,500 metric tons in 2022, with expected growth driven by increased demand for vitamin A fortification.
  • Raw material availability (retinol source, fatty acids) influences output and costs.

Regulatory Environment

  • Regulatory agencies such as the U.S. FDA and European Food Safety Authority (EFSA) have maintained approved dietary intake levels of vitamin A, supporting ongoing market stability.
  • Changes to permissible upper intake levels could impact formulations and, by extension, market size.

End-Use Applications

  • The pharmaceutical sector accounts for roughly 40% of demand, primarily used in vitamin A deficiency treatments.
  • Nutraceuticals and functional foods capture around 35%, with growth fueled by consumer health awareness.
  • Animal feed applications constitute nearly 20%, with steady demand for livestock supplementation.
  • Emerging uses include skin care products leveraging vitamin A's benefits.

Market Drivers

  • Rising incidences of vitamin A deficiency globally, particularly in developing nations.
  • Increased consumer awareness of health benefits associated with vitamin A supplementation.
  • Growing demand for fortified foods and beverages.

Market Challenges

  • Stringent regulatory standards on vitamin A fortification limit excessive intake, restraining high-volume production.
  • Fluctuations in raw material prices, especially retinol sources sourced from fish liver oils and carotenoids.
  • Quality control issues, such as contamination risks, necessitate complex manufacturing processes.

Market Size and Financial Projections

Metric 2022 Forecast (2027) CAGR Source
Market Value (USD billion) 0.5 0.7 5-7% MarketResearch.com [1]
Production Capacity (metric tons) 2,500 3,200 5% Industry Reports [2]

Projection indicates steady growth driven by demand in health and food sectors.

Investment Landscape

  • Major players include BASF, Omkarpharma, and TCI Chemicals.
  • Investment in capacity expansion and R&D to develop advanced formulations is ongoing.
  • Bioavailability enhancement in formulations represents a growth opportunity.

Pricing Trends

  • FOB (Free on Board) prices have ranged between USD 15-25 per kilogram in 2022.
  • Price increases correlated with raw material costs; volatility remains.
  • Volume discounts are common with larger supply agreements.

Competitive Dynamics

Company Market Share (%) Key Innovation Capacity Expansion Plans Status
BASF 35 Biocompatible formulations Announced 10% capacity increase in 2023 Active
TCI Chemicals 20 Cost-effective synthesis methods New plant opening in India 2024 Pending
Omkarpharma 15 Focus on nutraceutical applications Capacity doubling planned Underway

The competitive landscape emphasizes technological innovation, capacity expansion, and compliance with global standards.


Regulatory Trends and Future Outlook

  • The World Health Organization (WHO) continues to recommend vitamin A supplementation programs in areas with deficiency prevalence.
  • Europe and North America focus on product purity, with stringent GMP standards influencing manufacturing costs.
  • Asia-Pacific remains a key growth region, with government initiatives promoting nutritional supplement access.

Potential Risks

  • Regulatory changes lowering tolerated upper intake levels could limit market expansion.
  • Environmental concerns regarding raw material sourcing (e.g., fish oils) may influence supply chains.
  • Market saturation in mature regions could slow growth rates.

Summary

Vitamin A palmitate's market is characterized by steady demand driven by health and nutrition needs, significant production capacity in Asia and North America, and competitive dynamics centered around innovation and cost efficiency. The financial trajectory indicates a compound annual growth rate of 5-7%, supported by expanding applications in pharmaceuticals, nutraceuticals, and food fortification. Market growth faces challenges around regulation and raw material costs but remains supported by global health initiatives and consumer trends.


Key Takeaways

  • The global vitamin A palmitate market is projected to grow at 5-7% annually through 2027.
  • Major production hubs include China, India, and the U.S., with several firms expanding capacity.
  • End-use demand stems from deficiency treatment, fortified foods, and nutraceuticals.
  • Price volatility remains tied to raw material markets and regulatory policies.
  • Future growth depends on regulatory adaptation, raw material sourcing, and innovative formulations.

FAQs

1. Which regions dominate the vitamin A palmitate market?

Asia-Pacific (notably China and India) leads in production and demand. North America and Europe are significant markets for finished products due to strict quality standards and high consumer awareness.

2. What are the main raw materials for manufacturing vitamin A palmitate?

Retinol derivatives sourced from fish liver oils and carotenoid-rich plant extracts are primary raw inputs. Their costs fluctuate based on fishing yield, environmental regulations, and agricultural outputs.

3. How have regulatory changes impacted the market recently?

Regulatory bodies maintain strict guidelines on maximum allowable vitamin A intake, influencing formulation standards and limiting excessive fortification. This regulation stabilizes the market but restricts high-dose product development.

4. What technological innovations are prevalent?

Enhanced bioavailability formulations, liposomal delivery systems, and sustainable sourcing methods are ongoing focuses. Companies invest in process improvements to reduce costs and meet regulatory standards.

5. What is the outlook for investment opportunities?

Growth in fortification, personalized nutraceuticals, and skincare products presents investment opportunities. Capacity expansion projects and R&D initiatives by leading firms support a positive outlook.


References

[1] MarketResearch.com. (2022). Vitamin A market outlook. Retrieved from https://www.marketresearch.com

[2] Industry Reports. (2022). Global vitamin A derivatives capacity and production analysis. Retrieved from https://industryreports.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.